Sign in
4

Changes in Ownership

Rapport Therapeutics, Inc. Filed Acc 0001193125-26-222185

10% owner sold 133,618 shares at $40.24 ($5,377,323)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Third Rock Ventures V, L.P. 10% owner 2026-05-11 Sale 10b5-1 −133,618 $40.24 $5,377,323 6,299,097 D: show line 1 in the form
Open-market sales · 133,618 sh · avg $40.24 · $5,377,323
Loading xslF345X06/ownership.xml…